Rodney Turner is a seasoned professional with over three decades of experience in the life science tools industry. As a Board Member at Samplix since March 2019 and Principal at RWT Consulting, Inc. since March 2014, Rodney provides advisory services on M&A opportunities, particularly for non-US companies seeking insights into the US market. Previous roles include General Manager of the Cell & Gene Therapy Business Unit and VP of Global Mergers & Acquisitions at Fortis Life Sciences, along with significant contributions at AYOXXA Biosystems GmbH as CEO and Strategic Advisor. Leadership experience also extends to board positions with notable companies such as MedCision and Exiqon A/S. Rodney holds a BA in Biochemistry from Rice University (1979-1983).
This person is not in the org chart
This person is not in any teams
This person is not in any offices